Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA ...Middle East

HONG KONG, Dec. 23, 2024 /PRNewswire/ -- A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University (Shanghai Sixth People's Hospital) has discovered that an aptamer developed by HKBU can...

Hence then, the article about aptamer developed by hkbu for treating rare bone disease x linked hypophosphatemia receives orphan drug designation and rare pediatric disease designation by u s fda was published today ( Monday 23/12/2024 - 08:31 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA )

Also on site :

• Go Inside BTS ‘Tonight Show’ Taping, From Fan Jump-Scares to Jimmy Fallon Angling to Be ‘The 8th Member’
• Trump& 039;s Disapproval Rating Hits All-Time High, Fox News Poll Shows
• Lord of the Rings Trilogy Has Many Elements That Are Difficult to Watch in the Modern Day